BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF SOFOSBUVIR FROM HUMAN PLASMA
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 3
Abstract
Objective: This study points to build up and validate a simple methodology to quantify the most used drug sofosbuvir for the treatment of hepatitis C virus (HCV) infection, in human plasma by using atazanavir as an Internal Standard (IS) for preclinical studies and validate as per USFDA guidelines.Methods: Sofosbuvir was isolated from plasma samples by liquid-liquid extraction method using acetonitrile; good chromatographic separation was achieved on Kromasil Column (250 mm ×4.6 mm, 5 µm). The mobile phase consisted of 0.1 % orthophosphoric acid (OPA) buffer pH 2 and acetonitrile in the ratio of (68:32, v/v), respectively. The analysis time was 7 min at a flow rate 1 ml/min. The photodiode array detector (PDA) detection was carried out at 228 nm. The suggested method was validated by performing linearity, system suitability, specificity and sensitivity, accuracy and precision, recovery, ruggedness, stability studies. The method was validated as per USFDA guidelines.Results: The developed method resulted in retention times of sofosbuvir and IS were found out to be 4.7 and 4.2 min respectively. The calibration curves are linear (r2 = 0.999) over the concentration range of 0.050-2.0 µg/ml of plasma analytes concentration. LOQ value was found to be 0.050 µg/ml with precision and accuracy. Within-batch % mean accuracy of the method ranged between 96.00% and 109.09%, and within-batch and total precision, expressed as the coefficient of variation, was 1.40–10.33%. Overall percentage mean recovery of sofosbuvir from spiked plasma was 84.14%. All the validated parameters were found to be within the limit.Conclusion: A simple, accurate, precise, linear, rugged and rapid RP-HPLC method was developed for quantitative estimation of sofosbuvir in human plasma and should be suitable for conducting pharmacokinetics studies and therapeutic drug monitoring.
Authors and Affiliations
S. Madhavi, A. Prameela Rani
Keywords
Related Articles
- EP ID EP575718
- DOI 10.22159/ijpps.2017v9i3.16185
- Views 55
- Downloads 0
DESIGN AND SYNTHESIS OF 4-SUBSTITUTED QUINAZOLINE DERIVATIVES FOR THEIR ANTICONVULSANT AND CNS DEPRESSANT ACTIVITIES
Objective: The present work is designed to synthesise some isomeric new series of Quinazoline-4-one/4-thione derivatives, based on the pharmacophoric model of central nervous system (CNS) activity by structural modificat...
PHYTOCHEMICAL, ANTIOXIDANT, AND TRACE ELEMENT ANALYSIS OF ANTHELMINTIC PLANTS OF NORTH-EAST INDIA
Objective: Cynodon dactylon, Hibiscus rosa-sinensis, Elaeocarpus floribundus and Acorus calamus are anthelmintic medicinal plants of north-east India. Due to its pharmacological properties, the present study was aimed to...
SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF CEFEPIME, CEFAZOLIN SODIUM AND CEFALOTHIN SODIUM IN PURE AND PHARMACEUTICAL DOSAGE FORMS BY USING NINHYDRIN
Objectives: cefazolin sodium and cefalothin sodium are the broad spectrum of antibiotics, are mainly used to control gram positive and gram negative bacterial infections. Cefepime is used to treat moderate-severe nosocom...
SCREENING OF ANTIBACTERIAL AND ANTIFONGICAL ACTIVITY IN MARINE MACROALGAE AND MAGNOLIOPHYTEA FROM THE COAST OF TUNISIA
Objective: The present study was conducted to evaluate the antimicrobial and antifongical activity of Hexane, ethyl acetate and methanol extracts of thirteen marine spices from Tunisian coastline (Chebba and Sfax): five...
EVALUATION OF ANTIBACTERIAL AND HAEMOLYTIC ACTIVITY OF PHYTOCHEMICALS FROM FRESHWATER MICROALGA, EUGLENA VIRIDIS (EHREN)
Objective: The main aim of this research work was to evaluate the antibacterial and haemolytic activities of different extracts of Euglena viridis (E. viridis), a freshwater microalga.Methods: The solvent extraction has...